Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107.2 USD | +1.55% | +4.05% | +15.47% |
Financials (USD)
Sales 2024 * | 431M | Sales 2025 * | 653M | Capitalization | 6.61B |
---|---|---|---|---|---|
Net income 2024 * | -152M | Net income 2025 * | -104M | EV / Sales 2024 * | 15.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-47.5
x | P/E ratio 2025 * |
-64.7
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.95% | Free-Float | 99.1% |
Latest transcript on Blueprint Medicines Corporation
1 day | -0.75% | ||
1 week | +2.67% | ||
1 month | -1.35% | ||
3 months | +10.98% | ||
6 months | +46.51% | ||
Current year | +14.44% |
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 106.3 | +0.68% | 91 577 |
24-05-31 | 105.6 | -0.75% | 631,490 |
24-05-30 | 106.4 | +5.76% | 640,414 |
24-05-29 | 100.6 | -1.75% | 378,257 |
24-05-28 | 102.4 | -0.44% | 756,819 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.44% | 6.61B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- BPMC Stock